Literature DB >> 34331895

Association between pregnancy and long-term cardiac outcomes in individuals with congenital heart disease.

Shannon L Son1, Lauren L Hosek2, Miranda C Stein2, Amanda A Allshouse3, Anna B Catino4, Arvind K Hoskoppal5, Daniel A Cox5, Kevin J Whitehead5, Ian M Lindsay5, Sean Esplin6, Torri D Metz6.   

Abstract

BACKGROUND: As early life interventions for congenital heart disease improve, more patients are living to adulthood and are considering pregnancy. Scoring and classification systems predict the maternal cardiovascular risk of pregnancy in the context of congenital heart disease, but these scoring systems do not assess the potential subsequent risks following pregnancy. Data on the long-term cardiac outcomes after pregnancy are unknown for most lesion types. This limits the ability of healthcare practitioners to thoroughly counsel patients who are considering pregnancy in the setting of congenital heart disease.
OBJECTIVE: We aimed to evaluate the association between pregnancy and the subsequent long-term cardiovascular health of individuals with congenital heart disease. STUDY
DESIGN: This was a retrospective longitudinal cohort study of individuals identifying as female who were receiving care in two adult congenital heart disease centers from 2014 to 2019. Patient data were abstracted longitudinally from a patient age of 15 years (or from the time of entry into the healthcare system) to the conclusion of the study, death, or exit from the healthcare system. The primary endpoint, a composite adverse cardiac outcome (death, stroke, heart failure, unanticipated cardiac surgery, or a requirement for a catheterized procedure), was compared between parous (at least one pregnancy >20 weeks' gestation) and nulliparous individuals. By accounting for differences in the follow-up, the effect of pregnancy was estimated based on the time to the composite adverse outcome in a proportional hazards regression model adjusted for the World Health Organization class, baseline cardiac medications, and number of previous sternotomies. Participants were also categorized according to their lesion type, including septal defects (ventricular septal defects, atrial septal defects, atrioventricular septal defects, or atrioventricular canal defects), right-sided valvular lesions, left-sided valvular lesions, complex cardiac anomalies, and aortopathies, to evaluate if there is a differential effect of pregnancy on the primary outcome when adjusting for lesion type in a sensitivity analysis.
RESULTS: Overall, 711 individuals were eligible for inclusion; 209 were parous and 502 nulliparous. People were classified according to the World Health Organization classification system with 86 (12.3%) being classified as class I, 76 (10.9%) being classified as class II, 272 (38.9%) being classified as class II to III, 155 (22.1%) being classified as class III, and 26 (3.7%) being classified as class IV. Aortic stenosis, bicuspid aortic valve, dilated ascending aorta or aortic root, aortic regurgitation, and pulmonary insufficiency were more common in parous individuals, whereas dextro-transposition of the great arteries, Turner syndrome, hypoplastic right heart, left superior vena cava, and other cardiac diagnoses were more common in nulliparous individuals. In multivariable modeling, pregnancy was associated with the composite adverse cardiac outcome (36.4%% vs 26.1%%; hazard ratio, 1.83; 95% confidence interval, 1.25-2.66). Parous individuals were more likely to have unanticipated cardiac surgery (28.2% vs 18.1%; P=.003). No other individual components of the primary outcome were statistically different between parous and nulliparous individuals in cross-sectional comparisons. The association between pregnancy and the primary outcome was similar in a sensitivity analysis that adjusted for cardiac lesion type (hazard ratio, 1.61; 95% confidence interval, 1.10-2.36).
CONCLUSION: Among individuals with congenital heart disease, pregnancy was associated with an increase in subsequent long-term adverse cardiac outcomes. These data may inform counseling of individuals with congenital heart disease who are considering pregnancy.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  adult congenital heart disease; aortopathy; maternal aortopathy; maternal congenital heart disease; maternal heart disease; pregnancy with congenital heart disease

Mesh:

Year:  2021        PMID: 34331895      PMCID: PMC8748281          DOI: 10.1016/j.ajog.2021.07.015

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  15 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  Pregnancy Outcomes in Women With Heart Disease: The CARPREG II Study.

Authors:  Candice K Silversides; Jasmine Grewal; Jennifer Mason; Mathew Sermer; Marla Kiess; Valerie Rychel; Rachel M Wald; Jack M Colman; Samuel C Siu
Journal:  J Am Coll Cardiol       Date:  2018-05-29       Impact factor: 24.094

3.  Methods to achieve high interrater reliability in data collection from primary care medical records.

Authors:  Clare Liddy; Miriam Wiens; William Hogg
Journal:  Ann Fam Med       Date:  2011 Jan-Feb       Impact factor: 5.166

4.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

Review 5.  High-Risk Cardiac Disease in Pregnancy: Part II.

Authors:  Uri Elkayam; Sorel Goland; Petronella G Pieper; Candice K Silversides
Journal:  J Am Coll Cardiol       Date:  2016-07-18       Impact factor: 24.094

6.  Pregnancy-Related Mortality in the United States, 2011-2013.

Authors:  Andreea A Creanga; Carla Syverson; Kristi Seed; William M Callaghan
Journal:  Obstet Gynecol       Date:  2017-08       Impact factor: 7.661

7.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

8.  Impact of pregnancy on the cardiac health of women with prior surgeries for pulmonary valve anomalies.

Authors:  Torri D Metz; Sammy A Hayes; Clarisa Y Garcia; Anji T Yetman
Journal:  Am J Obstet Gynecol       Date:  2013-06-19       Impact factor: 8.661

9.  Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology.

Authors:  Iris M van Hagen; Eric Boersma; Mark R Johnson; Sara A Thorne; William A Parsonage; Pilar Escribano Subías; Agata Leśniak-Sobelga; Olga Irtyuga; Khaled A Sorour; Nasser Taha; Aldo P Maggioni; Roger Hall; Jolien W Roos-Hesselink
Journal:  Eur J Heart Fail       Date:  2016-03-22       Impact factor: 15.534

10.  Long-Term Cardiovascular Outcomes After Pregnancy in Women With Heart Disease.

Authors:  Samuel C Siu; Douglas S Lee; Mohammed Rashid; Jiming Fang; Peter C Austin; Candice K Silversides
Journal:  J Am Heart Assoc       Date:  2021-05-25       Impact factor: 5.501

View more
  1 in total

1.  Long-Term Cardiovascular Health After Pregnancy in Danish Women With Congenital Heart Disease. A Register-Based Cohort Study Between 1993 and 2016.

Authors:  Stine Kloster; Janne S Tolstrup; Dorte Guldbrand Nielsen; Lars Søndergaard; Søren Paaske Johnsen; Annette Kjær Ersbøll
Journal:  J Am Heart Assoc       Date:  2022-02-22       Impact factor: 6.106

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.